← All stocks

Royalty Pharma plc

RPRX Scheduled selling only

CIK 0001802768 #618 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$6.00M

$6.00M on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$6.00M

$0.00 against sales at will

By person

15 insiders · 1 transaction

83.6×

Pablo Legorreta holds 83.6 times base salary in stock. $78.43M of shares against $937.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Pablo Legorreta last reported holding, valued at $59.97, the price Class A Ordinary Shares was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hite Christopher

EVP & Chairman, Partnering

—

$6.00M (1) scheduled

−$6.00M

393,601

0.088%

$23.61M

+6.4%

Legorreta Pablo G.

CEO, Chairman of the Board

—

1,307,820

0.294%

$78.43M

+1,950%

Norden Gregory

Director

—

196,348

0.044%

$11.78M

+158.1%

DESOUZA ERROL B

Director

—

81,352

0.018%

$4.88M

+10.3%

Bassler Bonnie L

Director

—

79,181

0.018%

$4.75M

+35.5%

Fernandez Henry A

Director

—

65,324

0.015%

$3.92M

+24.0%

LOVE TED W

Director

—

58,393

0.013%

$3.50M

+26.3%

Engelbert Catherine M.

Director

—

55,673

0.013%

$3.34M

+27.9%

HODGSON DAVID C

Director

—

37,873

0.009%

$2.27M

+47.3%

Coric Vlad

Director

—

15,343

0.003%

$920.16K

—

WEATHERMAN ELIZABETH H

Director

—

13,103

0.003%

$785.82K

—

Urist Marshall

EVP, Research & Investments

—

8,252

0.002%

$494.89K

−82.3%

Ho Carole

Director

—

4,545

0.001%

$272.58K

—

Coyne Terrance P.

EVP & CFO

—

0.000%

$0.00

−100.0%

Lloyd George W.

EVP, Investments & CLO

—

0.000%

$0.00

−100.0%

Royalty Pharma plc

By person

Individual transactions

What was left out